Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities

NCT02654769 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.

NCT NCT02654769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities
Lead sponsor
Actavis Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2015
Completion date
September 30, 2015
Enrollment
441 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis